In this issue:
Funding Opportunities & Grant Portfolio
Funding Opportunity: NCI Community Oncology Research Program (NCORP)
The NCI Community Oncology Research Program (NCORP), approved by the NCI Board of Scientific Advisors in June, 2013, will bring state-of-the-art cancer prevention, control, treatment and imaging clinical trials, cancer care delivery research, and disparities studies to individuals in their own communities. NCORP builds upon the success of the NCI Community Clinical Oncology Program (CCOP) network, adds elements of the NCI Community Cancer Centers Program (NCCCP), and creates a network for cancer care delivery research. NCORP comprises research bases, community sites, and minority/underserved sites.
Funding Opportunity Announcements (FOA) for NCORP were released on November 8, 2013: RFA-CA-13-012; RFA-CA-13-013; RFA-CA-13-014. Letters of intent were due on December 8, 2013 and applications are due on January 8, 2014. Please refer to the NCI NCORP Web site for more information about the FOAs.
The NCI Division of Cancer Prevention (DCP) (lead: Dr. Worta McCaskill-Stevens) provides overall leadership for NCORP, and key components of the initiative are being conducted by the Division of Cancer Control and Population Sciences (DCCPS) Outcomes Research Branch (ORB) (lead: Dr. Steven Clauser), the Division of Cancer Treatment and Diagnosis (DCTD), and the Center to Reduce Cancer Health Disparities. For more information about this key initiative, read the news release.
Limited-Competition RFA Issued for Cervical Cancer Screening Process Data
A limited-competition RFA, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) - Revision to Enhance the Collection of Cervical Cancer Screening Data (U54; RFA-CA-14-001), was released on November 4, 2013. It solicits applications for the collection of cervical cancer screening process data from PROSPR research centers that were previously focused only on breast or colorectal cancer screening.
The PROSPR initiative, which is currently in its third year of funding, seeks to examine breakdowns in the cancer screening process (recruitment, screening, positive screen evaluation, diagnosis, referral for treatment) in order to identify process failures and potential remedies. Based on responses to the original RFA, three colorectal and three breast-focused research centers were funded, but only one cervical-focused research center was funded. This newly issued RFA, led by Dr. Paul Doria-Rose in ARP's Health Services and Economics Branch, will support collaborative research comparing the cervical cancer screening process in different high-risk populations and health care settings.
ARP's diverse grant portfolio, including investigators' names, project titles and abstracts, and links to publications, is found at http://cancercontrol.cancer.gov/grants/query.asp?program=ARP.
Profiles of specific grantee projects are posted on ARP's Grantee Research Highlights Web site.